Luca Benatti, Director at INTERCEPT PHARMACEUTICALS INC (ICPT), bought 800 shares at $139.86 ($112K) on 2014-12-15, disclosed to the SEC on 2014-12-15.
Open-market purchase of $112k ICPT by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |